A matrix completion method for drug response prediction in personalized medicine

被引:8
|
作者
Nguyen, Giang T. T. [1 ]
Duc-Hau Le [2 ]
机构
[1] Hanoi Univ Sci & Technol, Network Informat Ctr, 1 Dai Co Viet, Hanoi, Vietnam
[2] Thuyloi Univ, Sch Comp Sci & Engn, 175 Tay Son, Hanoi, Vietnam
关键词
Personalized medicine; matrix completion; drug responses; drug - cell line response; REGULARIZATION; SELECTION;
D O I
10.1145/3287921.3287974
中图分类号
TP301 [理论、方法];
学科分类号
081202 ;
摘要
One of the significant goals of personalized medicine is to provide the right treatment to patients based on their molecular features. Several big projects have been launched and generated a large amount of -omics and drug response data for cell lines of the human. These projects are very useful for testing of drug responses on cell lines before employing clinical trials on humans. However, a range of drugs and cell lines have not been tested yet. Thus, many computational methods attempt to predict such the responses to maximize the treatment efficiency and to minimize side-effects. These methods use not only known drug cell lines responses but also the similarity between drugs and between cell lines. Nevertheless,-omics data for cell lines which is used to calculate the cell-line similarities usually varies among platforms leading to heterogeneous results. Therefore, in this study, we propose a drug response prediction method (MCDRP) based on a matrix completion technique using only known drug cell lines response information to predict drug responses for untested cell lines. The method can impute responses for not only one at time but also all drugs simultaneously. In comparison with other methods, we found that our method achieved better performance for IC50 response measurement.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 50 条
  • [1] Personalized medicine: Genetic risk prediction of drug response
    Zhang, Ge
    Nebert, Daniel W.
    PHARMACOLOGY & THERAPEUTICS, 2017, 175 : 75 - 90
  • [2] An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression
    Liu, Chuanying
    Wei, Dong
    Xiang, Ju
    Ren, Fuquan
    Huang, Li
    Lang, Jidong
    Tian, Geng
    Li, Yushuang
    Yang, Jialiang
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 21 : 676 - 686
  • [3] Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
    Feng, Fangyoumin
    Shen, Bihan
    Mou, Xiaoqin
    Li, Yixue
    Li, Hong
    JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (07) : 540 - 551
  • [4] Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
    Fangyoumin Feng
    Bihan Shen
    Xiaoqin Mou
    Yixue Li
    Hong Li
    Journal of Genetics and Genomics, 2021, 48 (07) : 540 - 551
  • [5] Prediction of Cancer Drug Resistance and implications for Personalized Medicine
    Volm, Manfred
    Efferth, Thomas
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [6] Personalized medicine: Genetic risk prediction of drug response (vol 175, pg 75, 2017)
    Zhang, Ge
    Nebert, Daniel W.
    PHARMACOLOGY & THERAPEUTICS, 2018, 183 : 205 - 206
  • [7] Drug response prediction system for personalized cancer therapy
    Kurilov, R.
    Juraeva, D.
    Weese, D.
    Klein, T.
    Kapushesky, M.
    Brors, B.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S81 - S82
  • [8] Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis
    Wei, Monica
    Chu, Cong-Qiu
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2022, 36 (01):
  • [9] Neighborhood Constraint Matrix Completion for Drug-Target Interaction Prediction
    Fan, Xin
    Hong, Yuxiang
    Liu, Xiaohu
    Zhang, Yaogong
    Xie, Maoqiang
    ADVANCES IN KNOWLEDGE DISCOVERY AND DATA MINING, PAKDD 2018, PT I, 2018, 10937 : 348 - 360
  • [10] Prediction of drug side effects with transductive matrix co-completion
    Liang, Xujun
    Fu, Ying
    Qu, Lingzhi
    Zhang, Pengfei
    Chen, Yongheng
    BIOINFORMATICS, 2023, 39 (01)